10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-045860`
Period End Date	20120630
Filing Date	20120814
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	bpth-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 65 Income Statement 54 Cash Flow Statement 59

Balance Sheet 65 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$1.22M	USD	Point-in-time
Cash	`Cash`	$162.44K	USD	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$238.56K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$21.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$295.48K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$153.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.44K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$46.49K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$504.41K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.15M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	58.33M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	58.87M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	58.87M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.87M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	58.33M	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$839.57K	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	550,000.00	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$791.46K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.66M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.08M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.23M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.17M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$121.54K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.15K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$67.97K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$22.59K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$46.08K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$86.59K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$41.00K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.70K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$39.54K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$243.02K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$316.13K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$243.02K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$316.13K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,868,713 and 58,325,169 shares issued and outstanding as of 6/30/12 and 12/31/11, respectively	`CommonStockValue`	$58.87K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 58,868,713 and 58,325,169 shares issued and outstanding as of 6/30/12 and 12/31/11, respectively	`CommonStockValue`	$58.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$12.55M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$12.41M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$168.50K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$9.55M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$10.86M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.92M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.17M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.23M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	2 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	21 Qtrs
Revenue	`Revenues`	-	USD	21 Qtrs
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	2 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$6.56M	USD	21 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$324.57K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$483.48K	USD	2 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$252.17K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$674.81K	USD	2 Qtrs
Total operating expense	`OperatingExpenses`	$787.78K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$463.77K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.31M	USD	2 Qtrs
Total operating expense	`OperatingExpenses`	$11.18M	USD	21 Qtrs
Total operating expense	`OperatingExpenses`	$1.06M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-11.18M	USD	21 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-463.77K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.31M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.06M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-787.78K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.11K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$213.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.30K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$77.05K	USD	21 Qtrs
Interest income	`InvestmentIncomeInterest`	$742.00	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	21 Qtrs
Other expense	`OtherNonoperatingExpense`	$398.00	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$3.93K	USD	21 Qtrs
Other expense	`OtherNonoperatingExpense`	$91.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$269.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$271.00	USD	2 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$344.00	USD	2 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-56.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.03K	USD	2 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.02K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$317.60K	USD	21 Qtrs
Net Loss	`NetIncomeLoss`	$-462.75K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-787.84K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.31M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-10.86M	USD	21 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.24	USD	21 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.63M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.87M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	50.52M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51.65M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.69M	shares	21 Qtrs

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-462.75K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-787.84K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.31M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-10.86M	USD	21 Qtrs
Amortization	`AdjustmentForAmortization`	$96.61K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$104.47K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$888.08K	USD	21 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	2 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	21 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	21 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$18.50K	USD	2 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$34.07K	USD	2 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$2.98M	USD	21 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$240.66K	USD	2 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	$-244.48K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$142.48K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-88.40K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$295.48K	USD	21 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$46.49K	USD	21 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-27.85K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.95K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-73.11K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$243.02K	USD	21 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-26.04K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.08M	USD	21 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.03M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-375.65K	USD	2 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$25.00K	USD	2 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$37.55K	USD	2 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$884.71K	USD	21 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-884.71K	USD	21 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.55K	USD	2 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	21 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	21 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$264.71K	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.70M	USD	21 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.40M	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.12M	USD	21 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$264.71K	USD	2 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.40M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$983.09K	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$162.44K	USD	21 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-789.81K	USD	2 Qtrs
Cash, beginning of period	`Cash`	$1.22M	USD	Point-in-time
Cash, beginning of period	`Cash`	$162.44K	USD	Point-in-time
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$238.56K	USD	Point-in-time
Cash, end of period	`Cash`	$1.22M	USD	Point-in-time
Cash, end of period	`Cash`	$162.44K	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$238.56K	USD	Point-in-time
Interest	`InterestPaid`	$445.00	USD	21 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	21 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	21 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.